Camidanlumab tesirine, an antibody-drug conjugate, in relapsed/refractory CD25-positive acute myeloid leukemia or acute lymphoblastic leukemia: A phase I study
Titel:
Camidanlumab tesirine, an antibody-drug conjugate, in relapsed/refractory CD25-positive acute myeloid leukemia or acute lymphoblastic leukemia: A phase I study
Auteur:
Goldberg, Aaron D. Atallah, Ehab Rizzieri, David Walter, Roland B. Chung, Ki-Young Spira, Alexander Stock, Wendy Tallman, Martin S. Cruz, Hans G. Boni, Joseph Havenith, Karin E.G. Chao, Grace Feingold, Jay M. Wuerthner, Jens Solh, Melhem